Donald Trump’s choice to run the Department of Health and Human Services spooked investors who worry what Kennedy would do.
Category: Pfizer Inc
-
New York Times Takes European Commission to Court Over Covid Vaccine Deal
The news outlet is pushing the Commission to release text messages between the E.U.’s top official and Pfizer as they negotiated a vaccine contract.
-
U.S. Unveils Price Limits for 10 Costly or Common Medications
The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
-
U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations
The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
-
E.U. Court Rebukes European Commission Over Covid Vaccine Contracts
The court ruled that the European Commission wrongly withheld information, casting a shadow on its leader, Ursula von der Leyen, before a crucial vote on her future.
-
New Covid Vaccine Endorsed for Fall
The panel endorsed targeting a variant of the coronavirus that is now receding, though some officials suggested aiming at newer versions of the virus that have emerged in recent weeks.
-
Kansas City Stars, With Help From Taylor Swift, Are Advertising Champs
On-field success and a certain off-field relationship helped make Patrick Mahomes, Travis Kelce and Andy Reid ubiquitous on TV commercials during the N.F.L. season.
-
Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.
With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.
-
What the Biden-Xi Talks Accomplished (and Didn’t)
Wednesday’s four-hour meeting in San Francisco resulted in few breakthroughs. But C.E.O.s gave the Chinese leader a standing ovation at a banquet afterward.
-
Tornado Rips Through N.C. Site, Threatening Pfizer’s Drug Supplies
Extensive damage occurred at the company’s property in Rocky Mount, and many products used by hospitals appeared to have been affected. This could further exacerbate shortages.
-
Antibiotic Shortage Could Fuel Rise in Syphilis Rates
The primary drug used to treat the sexually transmitted infection could be scarce into next year, Pfizer warns.